HCA Healthcare Stock's 30.55% Trading Volume Surge Propels It to 218th in Activity

On August 13, HCA Healthcare (HCA) closed with a 0.04% gain, with a trading volume of $550 million, representing a 30.55% increase from the previous day’s volume. The stock ranked 218th in terms of trading activity on the day.

HCA and Mission Health reached a settlement in a federal antitrust lawsuit filed by Western North Carolina counties and municipalities. The agreement, announced on August 13, includes a $1 million donation by Mission Health to a new charity care fund for low-income residents earning up to 400% of the federal poverty level. The resolution also requires Mission Health to extend operations at Transylvania Regional Hospital in Brevard by an additional three years. Both parties denied any wrongdoing, stating their conduct complied with antitrust laws and that no contracts contained the challenged provisions.

Under the terms, Mission Health will collaborate to secure adult day care facilities in Brevard and pursue trauma center verification for Mission Hospital. Additional advisory board information will be shared with the plaintiff municipalities. The lawsuit, initially filed by Brevard in June 2022, alleged HCA used market power to enforce restrictive insurance contracts, limiting competition in acute care and outpatient services. Plaintiffs acknowledged the importance of HCA and Mission’s ongoing community support, particularly during Hurricane Helene recovery efforts.

The settlement avoids a protracted legal battle but does not resolve broader scrutiny of HCA’s market practices. Analysts note the charity fund and operational commitments may bolster local goodwill but are unlikely to significantly alter investor sentiment in the short term.

The strategy of buying the top 500 stocks by daily trading volume and holding them for one day from 2022 to now delivered moderate returns. The CAGR was 6.98%, with a maximum drawdown of 15.46% during the backtest period. The strategy demonstrated steady growth over time, making it a robust choice for investors seeking consistent returns. However, the significant drawdown in mid-2023 highlights the importance of risk management in such a volatile scenario.